When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DRNA - Dicerna earns $10M in milestone from Eli Lilly
Dicerna Pharmaceuticals Inc.
FDA has signed-off investigational new drug application ((IND)) filed by Eli Lilly ([[LLY]] +0.3%) for LY3561774, the first candidate to emerge from licensing collaboration between Dicerna ([[DRNA]] -3.8%), and Eli Lilly.The event has triggered a milestone payment of $10M from Eli Lilly, and Phase 1 trial for the candidate is expected to commence by the end of this year, for the treatment of an undisclosed cardiometabolic disease.